Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor Vβ domains

Journal of Virology

Volumn 75, Issue 16, 2001, Pages 7453-7461

  Baribaud, F ^a   Wirth, S ^a   Maillard, I ^a   Valsesia, S ^a   Acha Orbea, H ^a   Diggelmann, H ^a  

^a 225 Johnson Pavilion ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; BETA CHAIN; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENETIC VARIABILITY; IMMUNE RESPONSE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; SEQUENCE HOMOLOGY; VACCINIA VIRUS; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; ANTIGEN PRESENTATION; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SEQUENCE ALIGNMENT; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0034904678     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.16.7453-7461.2001     Document Type: Article

References (46)

1. Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading frame protein
2. Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus
3. Retrovirus-induced target cell activation in the early phases of infection: The mouse mammary tumor model
4. Alleles of highly homologous rat T cell receptor beta-chain variable segments 8.2 and 8.4: Strain-specific expression, reactivity to super-antigens, and binding of the mAb R78
5. Preferential binding of mouse mammary tumor virus to B lymphocytes
6. The V beta complementarity determining region 1 of a major histocompatibility complex (MHC) class I-restricted T cell receptor is involved in the recognition of peptide/MHC I and superantigen/MHC II complex
7. Expression of the mouse mammary tumor virus ORF gene in cultured cells
8. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus
9. V beta 17 gene polymorphism in wild-derived mouse strains: Two amino acid substitutions in the V beta 17 region greatly alter T cell receptor specificity
10. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary turnout virus
11. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens
12. Superantigens interact with MHC class II molecules outside of the antigen groove
13. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen
14. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex
15. Rat T cell responses to superantigens. II. Allelic differences in V beta 8.2 and V beta 8.5 beta chains determine responsiveness to staphylococcal enterotoxin B and mouse mammary tumor virus-encoded products
16. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection
17. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus
18. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission
19. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles
20. Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor
21. Enterotoxin residues determining T-cell receptor V beta binding specificity
22. T cell tolerance by clonal elimination in the thymus
23. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex
24. A standardized nomenclature for endogenous mouse mammary tumor viruses
25. The mouse mammary tumor virus long terminal repeat encodes a 47 kDa glycoprotein with a short half-life in mammalian cells
26. In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen
27. In vivo T cell response to viral superantigen. Selective migration rather than proliferation
28. TCR binding differs for a bacterial superantigen (SEE) and a viral superantigen (Mtv-9)
29. Mouse mammary tumor virus: Immunological interplays between virus and host
30. Clonal expansion precedes anergy and death of V beta 8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo
31. T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens
32. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus
33. Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen
34. Transposon-mediated random insertions and site-directed mutagenesis prevent the trafficking of a mouse mammary tumor virus superantigen
35. Analysis of the interaction site for the self superantigen Mls-1a on T cell receptor V beta
36. Identification of the region of T cell receptor beta chain that interacts with the self-superantigen MIs-1a
37. Coding sequence polymorphisms among V beta T cell receptor genes
38. The Ly45.1 alloantigen: Preferential expression on CD4(-)CD8(-)/CD4(+)CD8(+) thymocytes
39. Correlation between the V beta 4+ CDS+ T-cell population and the H-2d haplotype
40. Influence of T cell receptor V alpha expression on Mlsa superantigen-specific T cell responses
41. Skewed T cell receptor V alpha repertoire among superantigen reactive murine T cells
42. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity
43. The V beta-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice
44. Detection and biochemical characterization of the mouse mammary tumor virus 7 superantigen (Mls-1a)
45. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen
46. Direct evidence for the role of COOH terminus of mouse mammary tumor virus superantigen in determining T cell receptor V beta specificity